STOCK TITAN

Tamir Poleg Discloses Multiple REAX Share Sales in Form 144

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Real Brokerage Inc. (REAX) filed a Form 144 reporting a proposed sale of 50,000 common shares through Morgan Stanley Smith Barney LLC Executive Financial Services on 08/13/2025. The filing lists an aggregate market value of $223,650 and shows 208,121,000 shares outstanding for the issuer.

The Form states the shares were acquired on 08/13/2025 by stock option exercise from the issuer and payment was in cash. The filing also documents numerous sales by Tamir Poleg during May–August 2025 (examples include 100,000 shares on 06/03/2025 for $431,500 and 73,063 shares on 08/11/2025 for $301,311.81). The filer certifies no undisclosed material adverse information.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Insider exercised options and plans to sell 50,000 shares; multiple recent insider disposals are disclosed, appearing as routine insider liquidity.

The Form 144 shows a same-day option exercise and proposed sale of 50,000 REAX shares via Morgan Stanley with an aggregate value of $223,650. The issuer's outstanding share count is provided as 208,121,000, which contextualizes the size of the notice. The filing also catalogs many prior sales by Tamir Poleg across May–August 2025, including several large blocks. From a market-movement perspective, these are standard insider disclosures that increase transparency; they do not, on their face, indicate undisclosed operational issues because the filer affirms no material nonpublic information.

TL;DR: Form 144 documents compliant disclosure of an option exercise and planned sale; repeated insider sales warrant attention for governance and signaling.

The filing includes the required certification about material information and references trading-plan considerations. It records acquisition by stock option exercise and cash payment, and names the executing broker. The extensive list of sales by an individual named Tamir Poleg over recent months is relevant for governance review and insider trading oversight, though the filing itself is a routine compliance document rather than an operational disclosure.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 for Real Brokerage (REAX) disclose?

The Form 144 discloses a proposed sale of 50,000 common shares via Morgan Stanley with an aggregate market value of $223,650, approximately dated 08/13/2025.

How were the 50,000 shares acquired according to the filing?

The filing states the shares were acquired on 08/13/2025 by stock option exercise from the issuer, and payment was made in cash.

Who appears in the filing as having sold shares in the prior three months?

The filing lists numerous sales by Tamir Poleg during May–August 2025, with transaction examples and gross proceeds included.

What broker is named for the proposed sale in the Form 144?

The proposed sale lists Morgan Stanley Smith Barney LLC Executive Financial Services, 1 New York Plaza, New York, NY as the broker.

Does the filer assert any undisclosed material information?

Yes. The filer signs a certification that they do not know of any material adverse information